Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
December 2008
M&A Medtronic completed its minority investment in Shandong Weigao Group. As a result of the investment, Medtronic now holds a 15 percent equity stake in Weigao. Medtronic purchased its 15 percent equity interest in Weigao for approximately HK$1.7 billion (or... more
In an effort to individualize treatment for patients presenting with fractured bones as well as make treatment more cost-effective, the WHO has launched a web tool to help physicians assess the likelihood of future fractures. Knowing future fracture risk can... more
This morning Regen Biologics announced that it received its long awaited FDA 510(k) clearance to market its collagen meniscus implant for the knee. This marks the end of a long and tortured back and forth between the company and the... more
Beleaguered ArthroCare is down 70% in early trading this morning on news that it would broaden a previously-announced financial restatement and that several of the company's officers have resigned. Last July, company said they would restate financials from 2006, 2007... more
Last night, Stryker announced that the company is reducing its revenue and earnings outlook for 2008 on account of the "unprecedented weakening" of the U.S. economy. Constant-currency revenue growth, previously forecast to be 11-12% over 2007, is now expected to... more
Medtronic announced today that it had completed its long-awaited minority investment in Shandong Weigao Group. As a result of the investment, Medtronic now holds a 15 percent equity stake in Weigao. To facilitate the equity investment, Medtronic purchased its 15... more
With stock values down so much, particularly over the past few months, we took a look at the mergers & acquisition environment. We pulled information on M&A premiums on the NASDAQ and NYSE in the recent past, given the recent... more
Funding In addition to its regularly scheduled payments, Orthofix International will make a $10 million debt prepayment on December 29th in advance of the scheduled maturity. According to Executive Vice President and CFO Bob Vaters, "This is a good time... more
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today... more
The pinkie, asserts the New York Times, is not generally the most prized of one's fingers. Those distinctions usually go to the index finger, with its unparalleled ability to guide a fork and knife or mouse-click, or the sentimental ring... more
A new study published in JBJS considers how driving plays into patient outcomes following musculoskeletal injury. Interestingly, despite the relatively high rate of auto accidents in the general population, there are no firm guidelines for when a patient should resume... more
Earnings Wright Medical reiterated 4Q:08 revenue and earnings guidance on a call this week and lowered 2009 guidance based on less favorable foreign exchange rates. The company is now calling for 2009 revenues in the range of $510 million to... more
Wright Medical held their annual detailed guidance call yesterday, reiterating 4Q:08 revenue guidance in the $119 million to $122 million range. This affirms that revenue expectations will remain stable despite the macro economic climate. For the full year 2008, management... more
Imaging technology may be an ubiquitous part of modern medical practice, but a New York Times article suggests that the frequency and sensitivity of MRI and CT scans may reveal musculoskeletal abnormalities without showing what causes a patient's pain. These... more
CARLSBAD, Calif., Dec 09, 2008 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating... more
When George W. Bush took office in 2001, one of his first executive orders was to restrict federal funding of stem cell research based on his belief that destroying embryos to obtain the cells was equivalent to destroying human life.... more
We're running a five-question readership survey to help shape our Musculoskeletal blog coverage. It should take you about a minute, since there are no open-ended questions. The survey is here: 2008 HealthpointCapital Musculoskeletal Readership Survey. Anyone who completes the survey... more
Earnings Stryker announced a 2008 dividend of $0.40 per share, an increase of 21% over the 2007 dividend, which is payable January 30, 2009. President and CEO Stephen MacMillan said the increased dividend reflects the company's continued growth and strong... more
In a letter to Orthofix shareholders released this morning, Ramius LLC criticized the company's "irresponsible" management and called the Blackstone acquisition " a failure." Ramius, a fund that holds 4.7% of OFIX's stock, called for the sale of Blackstone as... more
Serotonin, most commonly known as the brain chemical that makes you happy, may play a different role in the body--regulating bone growth, according to new research in the journal Cell. This study focused on serotonin produced in the gut as... more
Complete Archive
|
